Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Achieve Life Sciences Inc (NASDAQ: ACHV) closed at $4.74 down -3.85% from its previous closing price of $4.93. In other words, the price has decreased by -$3.85 from its previous closing price. On the day, 0.75 million shares were traded. ACHV stock price reached its highest trading level at $5.035 during the session, while it also had its lowest trading level at $4.655.
Ratios:
For a deeper understanding of Achieve Life Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 21, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On November 14, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $12.
On September 27, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $20.Raymond James initiated its Strong Buy rating on September 27, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 18 ’25 when Oki Mark K sold 50,060 shares for $2.92 per share. The transaction valued at 146,175 led to the insider holds 127,940 shares of the business.
Stewart Richard Alistair sold 129,501 shares of ACHV for $378,143 on Sep 18 ’25. The Chief Executive Officer now owns 228,875 shares after completing the transaction at $2.92 per share. On Sep 04 ’25, another insider, Wan Jerry, who serves as the Principal Accounting Officer of the company, sold 14,070 shares for $2.77 each. As a result, the insider received 38,974 and left with 32,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 242237536 and an Enterprise Value of 196800544.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.69, which has changed by 0.06479478 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.78, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is 30.85%, while the 200-Day Moving Average is calculated to be 56.05%.
Shares Statistics:
For the past three months, ACHV has traded an average of 1.51M shares per day and 1110940 over the past ten days. A total of 49.69M shares are outstanding, with a floating share count of 41.28M. Insiders hold about 19.22% of the company’s shares, while institutions hold 53.94% stake in the company. Shares short for ACHV as of 1760486400 were 4735602 with a Short Ratio of 3.13, compared to 1757894400 on 4048565. Therefore, it implies a Short% of Shares Outstanding of 4735602 and a Short% of Float of 10.89.
Earnings Estimates
The stock of Achieve Life Sciences Inc (ACHV) is currently drawing attention from 6.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.23 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.06 and -$1.43 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$1.07, with 6.0 analysts recommending between -$0.6 and -$1.38.
